Affordable Access

deepdyve-link
Publisher Website

Statin use and risk of skin cancer.

Authors
  • Lin, Brian M1
  • Li, Wen-Qing2
  • Cho, Eunyoung3
  • Curhan, Gary C4
  • Qureshi, Abrar A3
  • 1 Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address: [email protected]
  • 2 Department of Dermatology, Warren Alpert Medical School, Providence, Rhode Island; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island.
  • 3 Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Department of Dermatology, Warren Alpert Medical School, Providence, Rhode Island; Department of Epidemiology, School of Public Health, Brown University, Providence, Rhode Island.
  • 4 Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts; Renal Division, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Type
Published Article
Journal
Journal of the American Academy of Dermatology
Publication Date
Apr 01, 2018
Volume
78
Issue
4
Pages
682–693
Identifiers
DOI: 10.1016/j.jaad.2017.11.050
PMID: 29208416
Source
Medline
Keywords
License
Unknown

Abstract

History of high cholesterol level was not associated with skin cancer risk. Longer duration of statin use was associated with a trend toward higher BCC risk in men.

Report this publication

Statistics

Seen <100 times